Olivia Hallisey developed a novel diagnostic Ebola test, the “Ebola Assay Card” (EAC). She determined early diagnosis was critical to arresting the epidemic’s exponential growth. The EAC is inexpensive, rapid, and visual, indicating results through a color change, eliminating language barriers, and increasing ease of use. Most recently, she has developed the “Lyme Assay Card” (LAC) for saliva-based early diagnosis of Lyme disease. She is continuing research on this assay as a broad disease diagnostic with applicability for other ELISA assay-based diseases.

She is currently studying at Stanford University.